Guy Jean Savoir – CEO, Carnot Laboratories
Guy Jean Savoir, CEO of family-run Mexican pharma Carnot Laboratories explains the company’s USD 150 million investment in a new facility, its plans to focus manufacturing efforts on vaccines and…
Address: Heriberto Frias #1035, Col. Del Valle, Mexico D.F.
Heriberto Frias #1035, Col. Del Valle, Mexico D.F.
Heriberto Frias #1035, Col. Del Valle, Mexico D.F.,Mexico
Tel:
Web: http://www.techsphere.com.mx/
Carnot Laboratories is a 100% Mexican company focused on high technology systems in the manufacturing of their products. The company considers the launch of innovative products and continuous product renewal the cornerstone of its growth in order to meet the current requirements of the population. Carnot’s manufacturing facilities have been certified by COFEPRIS, INVIMA, ANVISA and ANMAT and is now present all over Central and South America, with affiliates in Argentina, Peru, Colombia and Uruguay.
Carnot ® Laboratories adds value through its business philosophy, offering manufacturing in areas such as hormonal injectables, oral solids, oral liquids, semisolids, conditioning and inhaled biological products that meet national and international quality standards. Carnot products are based on years of experience and technological innovation.
Guy Jean Savoir, CEO of family-run Mexican pharma Carnot Laboratories explains the company’s USD 150 million investment in a new facility, its plans to focus manufacturing efforts on vaccines and…
Carnot is celebrating 70 years as a company. There have been a lot of changes over this time, but more specifically over the last three to four years, please can…
Organon’s recently-appointed LAMEX Cluster Head Julio Conejero lays out how Organon is committed to improving women’s health and addressing unmet needs through its portfolio. This mission aligns with the rise…
The lowest spender on healthcare as a percentage of GDP in mainland Latin America. A complex and fragmented reimbursement system. Clinical trial approval delays stretching across eight months. One could…
Hernán Porcile, General Manager of Takeda Mexico, discusses the company’s innovative therapies, regulatory strategies, and the integration of ” “Takeda-ism” within the Mexican cultural context. He emphasizes Takeda’s commitment to…
Oswaldo Bernal explains how Mexico is BMS’ top-performing market in Latin America (outside of Brazil) and plays a significant role in the company’s global growth strategy. He also discusses how…
The French Chamber of Commerce in Mexico (CCI France Mexico) has been helping French companies such as Sanofi, Servier and Pierre Fabre establish themselves in Mexico for 140 years. General…
Jorge Luis Caridad, managing director of Johnson & Johnson Innovative Medicine, Mexico, explores his 18-year journey within the company, emphasizing his alignment with J&J’s values and its mission to transform…
Founded in 1943, Mexican drugmaker Silanes has built a strong presence across multiple therapeutic areas, namely diabetes and cardiovascular, while expanding into others. The company’s director of pharma and biologics,…
Francisco Chavez from Thermo Fisher Scientific explains the company’s global mission to advance science and healthcare, with a particular focus on Latin America. Chavez highlights Thermo Fisher’s significant investment in…
Carlos Hernandez and Daniel Kilian discuss OECHSLER’s decision to diversify into the medical device industry, leveraging the company’s expertise in automotive manufacturing; how Mexico has become a crucial strategic hub…
Valney Suzuki highlights his focus on expanding access to Novo Nordisk’s innovations in Mexico, especially for vulnerable populations; the importance of ethical usage of the company’s groundbreaking semaglutide-based treatments for…
Pedro Casas Alatriste of AmCham Mexico delves into the chamber’s efforts to enhance U.S.-Mexico trade relations, support key industries, and promote sustainable growth amid Mexico’s political transition. We are…
David López García, a pharma industry executive and rare disease expert, discusses the challenges and advancements in treating rare diseases in Mexico. He highlights the importance of public-private partnerships and…
See our Cookie Privacy Policy Here
